Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Comment on "Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia?"

Avsar E.

J Matern Fetal Neonatal Med. 2019 Jul 24:1. doi: 10.1080/14767058.2019.1645111. [Epub ahead of print] No abstract available.

PMID:
31311409
2.

An analytical method to create patient-specific deformed bone models using X-ray images and a healthy bone model.

Ün MK, Avşar E, Akçalı İD.

Comput Biol Med. 2019 Jan;104:43-51. doi: 10.1016/j.compbiomed.2018.11.003. Epub 2018 Nov 5.

PMID:
30423529
3.

Comment on "Mean Platelet Volume: A Reliable Marker of Inflammation in Recurrent Aphthous Stomatitis and Behçet's Disease?"

Avsar E.

Indian Dermatol Online J. 2018 Jul-Aug;9(4):281. doi: 10.4103/idoj.IDOJ_59_18. No abstract available.

4.

Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer.

Felip E, Barlesi F, Besse B, Chu Q, Gandhi L, Kim SW, Carcereny E, Sequist LV, Brunsvig P, Chouaid C, Smit EF, Groen HJM, Kim DW, Park K, Avsar E, Szpakowski S, Akimov M, Garon EB.

J Thorac Oncol. 2018 Apr;13(4):576-584. doi: 10.1016/j.jtho.2017.11.131. Epub 2017 Dec 13.

5.

A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer.

van Geel RMJM, Tabernero J, Elez E, Bendell JC, Spreafico A, Schuler M, Yoshino T, Delord JP, Yamada Y, Lolkema MP, Faris JE, Eskens FALM, Sharma S, Yaeger R, Lenz HJ, Wainberg ZA, Avsar E, Chatterjee A, Jaeger S, Tan E, Maharry K, Demuth T, Schellens JHM.

Cancer Discov. 2017 Jun;7(6):610-619. doi: 10.1158/2159-8290.CD-16-0795. Epub 2017 Mar 31.

6.

Tumor necrosis factor-alpha inhibitors for the treatment of psoriasis patients with liver cirrhosis: A report of four cases with a literature review.

Ergun T, Seckin-Gencosmanoglu D, Salman A, Ozgen Z, Ocak ES, Avsar E, Imeryuz N.

Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):55-59. doi: 10.4103/0378-6323.186498. Review.

7.

Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.

Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar L.

Leuk Res. 2016 Jun;45:82-9. doi: 10.1016/j.leukres.2016.04.003. Epub 2016 Apr 11.

PMID:
27107658
8.

Psoriasis and the liver: problems, causes and course.

Tula E, Ergun T, Seckin D, Ozgen Z, Avsar E.

Australas J Dermatol. 2017 Aug;58(3):194-199. doi: 10.1111/ajd.12460. Epub 2016 Feb 24.

PMID:
26916498
9.

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis.

Öztürk E, Özbalak M, Berk S, Erdoğan I, Avşar E, Dolgun A, Çetiner M, Mandel NM, Yalnız FF, Elverdi T, Salihoğlu A, Eşkazan AE, Ar MC, Öngören Ş, Başlar Z, Aydın Y, Soysal T, Ferhanoğlu B.

Leuk Lymphoma. 2016 May;57(5):1211-4. doi: 10.3109/10428194.2015.1079319. Epub 2015 Oct 12. No abstract available.

PMID:
26294270
10.

Toxicity evaluation and source apportionment of Polycyclic Aromatic Hydrocarbons (PAHs) at three stations in Istanbul, Turkey.

Hanedar A, Alp K, Kaynak B, Avşar E.

Sci Total Environ. 2014 Aug 1;488-489:437-46. doi: 10.1016/j.scitotenv.2013.11.123. Epub 2013 Dec 15.

PMID:
24342492
11.

A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.

Avşar E, Tiftikçi A, Poturoğlu S, Erzin Y, Kocakaya O, Dinçer D, Yıldırım B, Güliter S, Türkay C, Yılmaz U, Onuk MD, Bölükbaş C, Ellidokuz E, Bektaş A, Taşan G, Aytuğ N, Ateş Y, Kaymakoğlu S.

Turk J Gastroenterol. 2013;24(4):316-21.

12.

Shear stress regulates late EPC differentiation via mechanosensitive molecule-mediated cytoskeletal rearrangement.

Cheng M, Guan X, Li H, Cui X, Zhang X, Li X, Jing X, Wu H, Avsar E.

PLoS One. 2013 Jul 2;8(7):e67675. doi: 10.1371/journal.pone.0067675. Print 2013.

13.

The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth.

Garon EB, Finn RS, Hamidi H, Dering J, Pitts S, Kamranpour N, Desai AJ, Hosmer W, Ide S, Avsar E, Jensen MR, Quadt C, Liu M, Dubinett SM, Slamon DJ.

Mol Cancer Ther. 2013 Jun;12(6):890-900. doi: 10.1158/1535-7163.MCT-12-0998. Epub 2013 Mar 14.

14.

Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.

Yilmaz Y, Eren F, Yonal O, Polat Z, Bacha M, Kurt R, Ozturk O, Avsar E.

Dis Markers. 2011;31(4):205-10. doi: 10.3233/DMA-2011-0815.

15.

Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease.

Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Ozdogan O, Celikel CA, Ulukaya E, Imeryuz N, Kalayci C, Avsar E.

Arch Med Res. 2011 Jan;42(1):38-43. doi: 10.1016/j.arcmed.2010.12.001.

PMID:
21376261
16.

Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease.

Yilmaz Y, Yonal O, Eren F, Kurt R, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E.

Clin Chem Lab Med. 2011 Jan;49(1):93-7. doi: 10.1515/CCLM.2011.022. Epub 2010 Nov 16.

PMID:
21077793
17.

Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease.

Yilmaz Y, Yonal O, Kurt R, Oral AY, Eren F, Ozdogan O, Ari F, Celikel CA, Korkmaz S, Ulukaya E, Imeryuz N, Kalayci C, Avsar E.

Scand J Clin Lab Invest. 2010 Dec;70(8):541-6. doi: 10.3109/00365513.2010.524933. Epub 2010 Oct 14.

PMID:
20942739
18.

Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats.

Tahan G, Eren F, Tarçin O, Akin H, Tahan V, Şahın H, Özdoğan O, İmeryüz N, Çelıkel Ç, Avşar E, Tözün N.

Turk J Gastroenterol. 2010 Sep;21(3):287-92.

19.

Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis.

Yilmaz Y, Yonal O, Kurt R, Ari F, Oral AY, Celikel CA, Korkmaz S, Ulukaya E, Ozdogan O, Imeryuz N, Avsar E, Kalayci C.

Ann Clin Biochem. 2010 Nov;47(Pt 6):549-53. doi: 10.1258/acb.2010.010169. Epub 2010 Oct 6.

PMID:
20926473
20.

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.

Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E.

Scand J Gastroenterol. 2011 Jan;46(1):91-7. doi: 10.3109/00365521.2010.516452. Epub 2010 Sep 1.

PMID:
20809771
21.

Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B.

Eren F, Yilmaz Y, Kose S, Ozdemir FT, Yonal O, Kurt R, Ozdogan O, Avsar E.

Clin Chim Acta. 2010 Dec 14;411(23-24):2029-32. doi: 10.1016/j.cca.2010.08.035. Epub 2010 Aug 31.

PMID:
20807521
22.

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.

Yilmaz Y, Eren F, Yonal O, Kurt R, Aktas B, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E.

Eur J Clin Invest. 2010 Oct;40(10):887-92. doi: 10.1111/j.1365-2362.2010.02338.x. Epub 2010 Aug 19.

PMID:
20624171
23.

Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.

Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, Alahdab YO, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E.

Metabolism. 2011 Apr;60(4):544-9. doi: 10.1016/j.metabol.2010.05.008. Epub 2010 Jun 26.

PMID:
20580037
24.

Cigarette smoking is not associated with specific histological features or severity of nonalcoholic fatty liver disease.

Yilmaz Y, Yonal O, Kurt R, Avsar E.

Hepatology. 2010 Jul;52(1):391; author reply 391-2. doi: 10.1002/hep.23718. No abstract available.

PMID:
20578155
25.

Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient.

Arslan F, Tabak F, Avşar E, Midilli K, Mert A, Ozaras R, Soysal T, Ozturk R, Ferhanoglu B.

J Neurovirol. 2010 Mar;16(2):174-8. doi: 10.3109/13550281003682539.

PMID:
20345320
26.

R72P polymorphism of TP53 in ulcerative colitis patients is associated with the incidence of colectomy, use of steroids and the presence of a positive family history.

Eren F, Akkiprik M, Atuğ O, Sönmez O, Tahan G, Ozdemir F, Hamzaoğlu HO, Celikel CA, Imeryüz N, Avşar E, Ozer A.

Pathol Oncol Res. 2010 Dec;16(4):563-8. doi: 10.1007/s12253-010-9255-9. Epub 2010 Mar 23.

PMID:
20309662
27.

The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.

Ozdemir FT, Tiftikci A, Sancak S, Eren F, Tahan V, Akın H, Gündüz F, Kedrah AE, Ustündağ Y, Avşar E, Tözün N, Ozdoğan O.

J Gastrointest Cancer. 2010 Sep;41(3):185-9. doi: 10.1007/s12029-010-9140-5.

PMID:
20306157
28.

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.

Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, Oflaz H, Ozdogan O, Imeryuz N, Kalayci C, Avsar E.

Atherosclerosis. 2010 Jul;211(1):182-6. doi: 10.1016/j.atherosclerosis.2010.01.049. Epub 2010 Feb 7.

PMID:
20181335
29.

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.

Yilmaz Y, Alahdab YO, Yonal O, Kurt R, Kedrah AE, Celikel CA, Ozdogan O, Duman D, Imeryuz N, Avsar E, Kalayci C.

Metabolism. 2010 Sep;59(9):1327-30. doi: 10.1016/j.metabol.2009.12.012. Epub 2010 Jan 22.

PMID:
20096896
30.

Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?

Tahan V, Ozaras R, Karaca C, Uraz S, Eren F, Danalioglu A, Avsar E, Turkoglu S, Midilli K, Tabak F, Ozturk R, Mert A, Senturk H, Tozun N.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1425-8.

PMID:
19950804
31.

The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats.

Canbakan B, Akin H, Tahan G, Tarcin O, Eren F, Atug O, Tahan V, Imeryuz N, Yapicier O, Avsar E, Tozun N.

Ann Hepatol. 2009 Jul-Sep;8(3):234-40.

32.

Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats.

Tahan V, Atug O, Akin H, Eren F, Tahan G, Tarcin O, Uzun H, Ozdogan O, Tarcin O, Imeryuz N, Ozguner F, Celikel C, Avsar E, Tozun N.

J Pineal Res. 2009 May;46(4):401-7. doi: 10.1111/j.1600-079X.2009.00676.x. Epub 2009 Mar 25.

PMID:
19552763
33.

Trial outcome and associative learning signals in the monkey hippocampus.

Wirth S, Avsar E, Chiu CC, Sharma V, Smith AC, Brown E, Suzuki WA.

Neuron. 2009 Mar 26;61(6):930-40. doi: 10.1016/j.neuron.2009.01.012.

34.

Role of capsule endoscopy in blue rubber bleb nevus syndrome.

Barlas A, Avsar E, Bozbas A, Yegen C.

Can J Surg. 2008 Dec;51(6):E119-20. No abstract available.

35.

Effects of rosiglitazone on methionine-choline deficient diet-induced nonalcoholic steatohepatitis.

Tahan V, Imeryuz N, Avsar E, Celikel C, Tozun N.

Hepatology. 2007 Dec;46(6):2045; author reply 2045-6. No abstract available.

PMID:
18046722
36.

Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity.

Uraz S, Tahan V, Aygun C, Eren F, Unluguzel G, Yuksel M, Senturk O, Avsar E, Haklar G, Celikel C, Hulagu S, Tozun N.

Dig Dis Sci. 2008 Apr;53(4):1071-7. Epub 2007 Oct 13.

PMID:
17934844
37.

Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death.

Imeryuz N, Tahan V, Sonsuz A, Eren F, Uraz S, Yuksel M, Akpulat S, Ozcelik D, Haklar G, Celikel C, Avsar E, Tozun N.

J Hepatol. 2007 Dec;47(6):851-9. Epub 2007 Aug 13.

PMID:
17825453
38.

Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis.

Tahan V, Eren F, Avsar E, Yavuz D, Yuksel M, Emekli E, Imeryuz N, Celikel C, Uzun H, Haklar G, Tozun N.

Dig Dis Sci. 2007 Dec;52(12):3465-72. Epub 2007 Apr 10.

PMID:
17436085
39.

Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey.

Ozdemir FT, Duman D, Ertem D, Avşar E, Eren F, Ozdoğan O, Kalayci C, Aslan N, Bozdayi AM, Tözün N.

Turk J Gastroenterol. 2005 Dec;16(4):183-7.

40.

Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?

Duman DG, Celikel C, Tüney D, Imeryüz N, Avsar E, Tözün N.

Dig Dis Sci. 2006 Feb;51(2):346-51.

PMID:
16534679
41.

Prothrombotic gene mutations and Crohn's disease; is there any association?

Over-Hamzaoglu H, Abaci N, Türe F, Alkim C, Tezel A, Avsar E, Tözün N.

Hepatogastroenterology. 2005 Sep-Oct;52(65):1467-9.

PMID:
16201098
42.

Octreotide in liver cirrhosis: a salvage for variceal bleeding can be a gunshot for kidneys.

Güney Duman D, Tüney D, Bilsel S, Benli F, Karan S, Avsar E, Ozdogan O, Tözün N.

Liver Int. 2005 Jun;25(3):527-35.

PMID:
15910489
43.

Sexual transmission of HCV between spouses.

Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, Avsar E, Mert A, Besisik F, Kaymakoglu S, Senturk H, Cakaloglu Y, Kalayci C, Okten A, Tozun N.

Am J Gastroenterol. 2005 Apr;100(4):821-4.

PMID:
15784025
44.

D-dimer--can it be a marker for malignant gastric lesions?

Aliustaoglu M, Yumuk PF, Gumus M, Ekenel M, Bolukbas F, Bolukbas C, Mutlu N, Basaran G, Avsar E, Turhal NS.

Acta Oncol. 2004;43(8):770-1. No abstract available.

PMID:
15764225
45.

Prevalence of hepatic granulomas in chronic hepatitis B.

Tahan V, Ozaras R, Lacevic N, Ozden E, Yemisen M, Ozdogan O, Mert A, Tabak F, Avsar E, Celikel CA, Ozbay G, Kalayci C, Senturk H, Tozun N.

Dig Dis Sci. 2004 Oct;49(10):1575-7.

PMID:
15573907
46.

Oral glucose tolerance deteriorates in rats fed with methionine choline deficient diet.

Tahan V, Yavuz D, Imeryuz N, Avsar E, Tozun N.

J Hepatol. 2004 Aug;41(2):352; author reply 353. No abstract available.

PMID:
15288488
47.
48.

Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury.

Gencosmanoglu R, Kurtkaya-Yapicier O, Tiftikci A, Avsar E, Tozun N, Oran ES.

J Clin Gastroenterol. 2004 Jul;38(6):484-9.

PMID:
15220682
49.

The prevalence of hepatic granulomas in chronic hepatitis C.

Ozaras R, Tahan V, Mert A, Uraz S, Kanat M, Tabak F, Avsar E, Ozbay G, Celikel CA, Tozun N, Senturk H.

J Clin Gastroenterol. 2004 May-Jun;38(5):449-52.

PMID:
15100526
50.

Anti-HCV seroprevalence in chronic HCV patients' children in Turkey.

Tahan V, Yildirim B, Ture F, Giral A, Ozdogan O, Imeryuz N, Avsar E, Mert A, Senturk H, Kalayci C, Tozun N.

J Clin Gastroenterol. 2004 Jan;38(1):90-1. No abstract available.

PMID:
14679341

Supplemental Content

Support Center